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We studied the distribution of porcine reproductive and respiratory syndrome virus (PRRSV) RNA in tissues
by in situ hybridization at different times postinfection (p.i.). The probe used for in situ hybridization was
prepared by reverse transcription of PRRSV RNA, followed by PCR amplification of the cDNA. The sequence
amplified corresponded to 433 bp from PRRSV open reading frame 7, which is contained in the nucleocapsid
protein gene and which is highly conserved in both European and American strains (H. Mardassi, L. Wilson,
S. Mounir, and S. Dea, J. Clin. Microbiol. 32:2197–2203, 1994). An immunohistochemical technique was used
to detect PRRSV antigen in tissue from virus-infected animals by using a monoclonal antibody specific for the
PRRSV nucleocapsid protein (E. A. Nelson, J. Christopher-Hennings, T. Drew, G. Wensvoort, J. E. Collins, and
D. A. Benfield, J. Clin. Microbiol. 31:3184–3189, 1993). The detection of PRRSV RNA was conducted in tissues
of 6-week-old pigs that had been infected with one of three different field PRRSV isolates and collected at times
ranging from 4 to 42 days p.i. Hybridization signals specific for PRRSV RNA were detected in lung, lymphoid
tissues, alveolar macrophages (obtained by lavage at the time of necropsy), Peyer’s patches, and kidney. The
PRRSV-positive cells in these tissues appeared to be predominantly macrophages. In lung tissue we also
obtained evidence suggesting the involvement of type II pneumocytes in the replication of PRRSV. During the
acute period of infection there was a close correlation between the detection of RNA and the detection of
nucleocapsid protein in individual cells. At later times p.i. (28 and 42 days p.i.), instead, more cells containing
only PRRSV RNA than those containing PRRSV RNA and also expressing PRRSV nucleocapsid protein were
detected. These results suggest that PRRSV RNA might persist in the tissues of infected animals for a longer
time than PRRSV antigen expression.
Porcine reproductive and respiratory syndrome virus
(PRRSV) is a spherical, enveloped virus classified in the genus
Arterivirus, together with equine arteritis virus, lactate dehy-
drogenase-elevating virus, and simian hemorrhagic fever virus
(10, 28). The virion of PRRSV is 50 to 65 nm in diameter, with
a central isometric nucleocapsid of approximately 30 to 35 nm
in diameter. The genome of PRRSV is a single-stranded poly-
adenylated RNA molecule of positive polarity and of approx-
imately 15 kb in length which contains eight open reading
frames (ORFs). The nucleocapsid protein is encoded by ORF
7 and is highly conserved among both European and North
American isolates (23, 25).
Epidemiological data indicate that reproductive and respi-
ratory forms of porcine reproductive and respiratory syndrome
are now endemic in domestic pigs of the United States and
Europe. The acute pathogenesis of porcine reproductive and
respiratory syndrome has been studied by numerous investiga-
tors by the use of virus isolation and immunohistochemical
(IHC) techniques (9, 14–16, 18, 21, 29). However, little is
known about the chronic effects of PRRSV infection. PRRSV
is known to persist as a subclinical infection in individual ani-
mals for a long period of time (32) and therefore may be
transmitted by contact or through semen to uninfected animals
(2, 7, 8). Since the first application of in situ hybridization
(ISH) to experimental virology in the early 1980s (13), this
technique has been significantly improved and is now widely
used because of its high degree of sensitivity and its ability to
resolve viral gene expression. The development of ISH for the
detection of PRRSV genomic RNA within infected tissue sec-
tions should make it possible to trace the path of the virus in
the natural host throughout long postinfection (p.i.) periods
with greater sensitivity.
A PRRSV-specific cDNA probe was produced by reverse
transcription (RT)-PCR amplification of a segment of ORF 7
and was used to detect PRRSV nucleic acids in tissues and
porcine alveolar macrophages (PAMs) of pigs infected intra-
nasally with PRRSV. After infection of the pigs, PRRSV-
positive cells were primarily distributed in the lung, lymphoid
tissues, Peyer’s patches of the ileum, and kidney. In particular,
significant numbers of PRRSV-positive cells, morphologically
consistent with macrophages, were detected in lung and lym-
phoid tissues throughout the study and up to the longest period
studied (42 days p.i.).
MATERIALS AND METHODS
Virus strains and cells. For optimization of ISH in cell cultures, we used the
NVSL strain of PRRSV (obtained from the National Veterinary Services Lab-
oratory, Animal and Plant Health Inspection Service, U.S. Department of Ag-
riculture, Ames, Iowa) to inoculate MARC-145 cells (kindly provided by J.
Kwang, Meat Animal Research Center, U.S. Department of Agriculture, Clay
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Center, Nebr.). PRRSV strains 94-2367 and 1534 (kindly provided by David
Benfield, South Dakota State University) and NEB-1 (provided by one of us [R.
A. Hesse]) were used to infect pigs in several experiments of PRRSV strain
pathogenesis which were the source of tissues for our study (11, 11a). MARC-145
cells (17) were infected at various multiplicities of infection. Viral identification
was confirmed by indirect immunofluorescence in infected MARC-145 and in
PAMs with monoclonal antibody (MAb) SDOW-17 (obtained from the National
Veterinary Services Laboratory), which recognizes a conserved epitope of the
PRRSV nucleocapsid protein (27).
Preparation of PRRSV-infected cell cultures for ISH. PRRSV-infected and
noninfected MARC-145 cell cultures were used as the starting material for
optimization of ISH. The cells were grown to confluency in Eagle’s minimum
essential medium with 5% fetal bovine serum. MARC-145 monolayers (75-cm2
flasks) were infected with PRRSV at a multiplicity of infection of 1. The medium
was removed when the cultures showed a 50 to 60% cytopathic effect, and the
cells were suspended by trypsinization. The harvested cells were applied to
Superfrost/plus slides (Fisher Scientific, Pittsburgh, Pa.) by centrifugation at
200 3 g for 5 min in a cytocentrifuge at a density of 105 cells per spot and were
fixed in PLP (4% paraformaldehyde, 100 mM L-lysine dihydrochloride, 10 mM
sodium m-periodate in phosphate-buffered saline [PBS; pH 7.4]) fixative for 5
min. The slides were then washed twice in PBS (pH 7.4) for 5 min and dehy-
drated through an ethanol series (70, 80, and 100%; 5 min at each concentra-
tion). The dehydrated slides were stored at 48C until use.
Source of tissue samples and PAMs. Tissues fixed in 10% buffered-neutral
formalin were obtained from two groups of 20 6-week-old pigs which were each
inoculated with one of two field strains of PRRSV (PRRSV 94-2367 or PRRSV
1534, respectively) for a comparative study of PRRSV pathogenesis (11a). One
group of 10 pigs remained uninfected and was used as a control group in the
study. The pigs were inoculated intranasally with 3 ml (in each nare) of 104 50%
cell culture infective doses of PRRSV per ml. Control pigs were inoculated in a
similar manner with a mock-infected MARC-145 cell culture supernatant. PAMs
and tissues were collected from one animal in each one of the three groups at
days 4, 7, 14, and 42 p.i. Tissues from one control animal and from three animals
of each PRRSV-inoculated group were collected on days 4, 7, and 14 p.i. Finally,
tissues from five animals in each of the three groups were collected on day 42 p.i.
Of these samples, tissues from three pigs of each group were randomly selected
for ISH and IHC. In addition, tissues collected at 28 days p.i. during a separate
experiment involving PRRSV NEB-1-challenged pigs (11) were also used for
simultaneous ISH and IHC.
Extraction of genomic RNA. PRRSV NVSL-infected MARC-145 cells (75-cm2
flask) were harvested when 70 to 80% of the cells were affected by cytopathic
changes. RNA was extracted from infected cells with the Trizol LS Reagent
(Gibco BRL, Grand Island, N.Y.) according to the manufacturer’s instructions.
The RNA contents of the PRRSV-infected MARC-145 extracts were estimated
by measuring the A260 with a Milton Roy Spectronic 601 spectrophotometer.
One microgram of total RNA extracted from PRRSV-infected MARC-145 cells
was used as the template for RT. Total RNA was extracted from mock-infected
MARC-145 cell cultures in a similar manner.
Primers. The primers from the PRRSV ORF 7 sequence amplification were
published by Mardassi et al. (23). The sense (1010 PLS) and antisense (1011
PLR) primers were 59-ATGGCCAGCCAGCCAGTCAATCA-39 (nucleotides
51 to 69) and 59-TCGCCCTAATTGAATAGGTG-3 (nucleotides 464 to 483),
respectively. This primer pair has been shown to amplify both North American
and European strains of PRRSV (22, 23).
RT-PCR. Twenty-five picomoles of antisense primer was added to 1 mg of
extracted RNA in 7 ml of diethyl pyrocarbonate (DEPC; Sigma, St. Louis,
Mo.)-treated water, denatured at 758C for 10 min, and then cooled on ice. RT
was performed in a final volume of 20 ml containing 13 RT buffer (50 mM
Tris-HCl [pH 8.3], 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol), 0.5 mM
(each) deoxynucleotide triphosphates (dNTPs), 1 U of RNase inhibitor per ml,
and 200 U of RNase H2 reverse transcriptase (Gibco BRL). After incubation for
1 h at 428C, the mixture was heated at 958C for 5 min and chilled on ice. A PCR
was set up with 20 ml of the RT product in 100 ml of 13 PCR buffer (10 mM
Tris-HCl [pH 9.0], 50 mM KCl, 2.5 mM MgCl2, 0.2 mM [each] dNTPs, and 25
pmol of each of the sense and antisense primers). After the addition of 2.5 U of
Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk, Conn.) and a thin layer of
mineral oil (Sigma), the PCR mixtures were cycled 35 times through denatur-
ation at 948C for 1 min, annealing at 608C for 1 min, and elongation at 728C for
2 min as described by Mardassi et al. (23). For product visualization, 10 ml of the
amplified RT-PCR products were analyzed by 2% agarose gel electrophoresis
and ethidium bromide staining. The 433-bp cDNA fragment was purified from
the agarose gel with GENECLEAN (Bio 101, Inc., La Jolla, Calif.).
Labeling and specificity control of the cDNA probe. The cDNA probe specific
for a region of ORF 7 in PRRSV was labeled by a random priming reaction with
digoxigenin-dUTP (DIG; Boehringer Mannheim Corp., Indianapolis, Ind.). This
cDNA represents a region of the PRRSV genome that is present in all sub-
genomic mRNAs and therefore provides a high degree of sensitivity by hybrid-
izing with all species of PRRSV RNA (sense and antisense genomic RNAs and
subgenomic mRNAs) present in infected cells.
The specificity of the labeled cDNA probe was confirmed by slot blot hybrid-
ization with RNA fractions obtained from PRRSV-infected and mock-infected
MARC-145 cells by using a Bio-Rad 48-well slot format Bio-Dot SF apparatus
and Zeta-Probe membrane (Bio-Rad, Herculeus, Calif.).
Pretreatment of slides for ISH. All solutions used for pretreatment, prehy-
bridization, and hybridization were treated with 0.1% DEPC-treated water. Cells
and tissue sections (5-mm thickness) were rehydrated and equilibrated in PBS for
3 min. Deproteinization was carried out in 0.2 N HCl for 20 min at room
temperature; this was followed by washing with DEPC-treated water for 1 min
and by digestion with proteinase K (Gibco BRL) at 4 mg/ml for cells and 20
mg/ml for tissues for 20 min in PBS at 378C. Serial sections of each infected tissue
sample were treated with RNase A (Boehringer Mannheim) at 100 mg/ml in 10
mM Tris-Cl (pH 7.4) for 30 min at 378C to remove target RNA as a specificity
control. After digestion, all cells and tissues were fixed in 4% paraformaldehyde
in PBS for 5 min. After rinsing with PBS twice, the slides were acetylated in 300
ml of 0.1 mM triethanolamine-HCl buffer (pH 8.0) to which 0.75 ml of acetic
anhydride (0.25%) was added. After 5 min, 0.75 ml of acetic anhydride was
added for an additional 5 min and the slides were then rinsed in 23 SSC (13 SSC
is 150 mM NaCl plus 15 mM sodium citrate [pH 7.0]).
ISH. The prehybridization mixture contained 50% deionized formamide, 43
SSC, 10% dextran sulfate, 13 Denhardt’s solution (0.02% Ficoll 400, 0.02%
polyvinylpyrrolidone, 0.02% bovine serum albumin), 2 mM EDTA, and 500 mg
of salmon testis DNA (Sigma) per ml. The slides were covered with 200 ml of
prehybridization mixture and were incubated in a humidified chamber for 1 h at
658C. A heterologous cDNA probe of 346 bp from the pseudorabies virus gG
glycoprotein gene was also labeled with DIG and was applied to the PRRSV-
infected tissues as a specificity control. The labeled probes (0.1 ng/ml) were
diluted in 300 ml of the prehybridization mixture and then heated for 5 min in a
958C heating block and quenched on ice before being applied to the cells and
tissue sections. The slides were rinsed briefly in 23 SSC, and 25 ml of probe
mixture for cells and 70 ml of probe mixture for tissues was applied to each slide.
The hybridization was performed overnight at 568C. After hybridization, the cells
and tissue sections were washed twice in 43 SSC for 5 min at room temperature,
once in 23 SSC for 10 min at 378C, once in 0.23 SSC containing 60% formamide
for 10 min at 378C, twice in 23 SSC for 5 min at room temperature, twice in 0.23
SSC for 5 min at room temperature, and once in buffer I (100 mM maleic acid,
150 mM NaCl [pH 7.5]) for 5 min at room temperature.
Immunohistological detection of hybridized cDNA probe. To reduce back-
ground staining the slides were preincubated with buffer II (1% blocking reagent
in buffer I; Boehringer Mannheim) for 40 min at room temperature. The anti-
DIG–alkaline phosphatase conjugate (Boehringer Mannheim) was freshly di-
luted to 1:500 in buffer II and was then added to the cells and tissue sections. This
incubation was carried out for 1 h in a humidified chamber at room temperature.
All incubations were followed by washes in two changes of buffer I for 5 min at
room temperature and once in buffer III (100 mM Tris-HCl, 100 mM NaCl, 50
mMMgCl2 [pH 9.5]) for 5 min at room temperature. Finally, the cells and tissue
sections were incubated with color substrate solution. The color solution con-
sisted of 45 ml of nitroblue tetrazolium salt (75 mg/ml in 70% dimethyl form-
amide) and 35 ml of 5-bromo-4-chloro-3-indolylphosphate, toluidinium salt (X-
phosphate; 50 mg/ml in dimethyl formamide), in 10 ml of buffer III. The reaction
was incubated for 3 to 8 h in the dark. The color reaction was stopped with TE
buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]). Counterstaining was done with
0.5%methyl green, and the slides were then washed with distilled water for 1 min
and dried completely. The slides were dipped in xylene, and then cover slips were
applied with a mounting solution of polyvinyl alcohol-vinyl acetate (Permount)
before microscopic examination.
IHC. Paraffin-embedded sections were cut to thicknesses of 4 to 5 mm, placed
on Superfrost/plus slides, and stained by a modification of the procedure of
Halbur et al. (14). Briefly, endogenous peroxidase activity was removed by one
30-min incubation in 3% hydrogen peroxide in PBS (pH 7.4) and then a wash in
Tris buffer (50 mM Tris buffer [pH 7.6]); tissue sections were then digested with
0.05% protease (Protease XIV; Sigma) in Tris buffer for 5 min at 378C. Non-
specific antibody binding was blocked by incubation with 1.5% normal goat
serum (Sigma). For primary immunostaining of PRRSV nucleocapsid antigen
(MAb SDOW-17), sections were incubated with the MAb (ascitic fluid, diluted
1:500) or normal goat serum (negative control) overnight at 48C; this was fol-
lowed by incubation for 45 min at room temperature with biotinylated goat
anti-mouse linking antibody (Dako Corp., Carpinteria, Calif.) for 30 min. The
sections were then treated with peroxidase-conjugated streptavidin (Dako Corp.)
for 30 min. Finally, the sections were incubated with 0.016% 3,39-diaminoben-
zidine tetrahydrochloride (Sigma) and 0.05% H2O2 for 4 to 5 min at room
temperature and were counterstained with Mayer’s hematoxylin-eosin. The
slides were covered with cover slips by using mounting medium (Polysciences,
Inc., Warrington, Pa.). For primary immunostaining of swine macrophages, sec-
tions of spleens and other lymphoid tissues from healthy pigs were incubated
with different dilutions (1:100 through 1:1,000) of ascitic fluid from two hybrid-
omas producing MAbs against swine macrophages which are available from the
American Type Culture Collection (3).
Virological assays. Assessment of viremia and infectivity in tissue homoge-
nates was carried out on the samples taken at days 4, 7, 14 and 42 days p.i. from
three animals in each of the two inoculated groups (PRRSV 94-2367 and
PRRSV 1534). For these assays the samples were processed and inoculated onto
monolayers of PAMs in 96-well, flat-bottom microtiter plates as described pre-
viously (11).
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RESULTS
Experimental inoculations. Compared with the uninocu-
lated controls, a remarkable clinical observation in the PRRSV
94-2367- and PRRSV 1534-inoculated groups consisted of in-
creased rectal temperature within 12 h of inoculation, which
remained elevated for approximately 20 days p.i. in one animal
(in the PRRSV 94-2367-inoculated group) and 9 days p.i. in
another animal (in the PRRSV 1534-inoculated group). In
both animals other clinical signs were similar to those de-
scribed previously in pigs of a similar age experimentally inoc-
ulated with the PRRSV NEB-1 strain (11) and consisted of
lethargy, moderate respiratory dyspnea, and cutaneous ery-
thema. Of the two PRRSV-inoculated groups, clinical signs
were consistently more prominent in the PRRSV 94-2367-
inoculated group (11a). Significant gross pathological lesions
consisted of moderate to marked enlargement of bronchial
lymph nodes. Lung pathology was observed within 4 days p.i.
and increased in severity to 14 days p.i. A diffuse tan discolor-
ation and consolidation were consistent findings in both cases.
ISH and IHC signals. PRRSV sequences were detected by
use of an anti-DIG–alkaline phosphatase conjugate when
PRRSV-infected MARC-145 cells were hybridized with a spe-
cific DIG-labeled PRRSV cDNA (433-bp) probe. The PRRSV
nucleic acid signal was specific because this was completely
absent from mock-infected MARC-145 cells (Fig. 1A and B).
ISH was used to determine the time of appearance of PRRSV-
positive signals in PAMs obtained by bronchial lavage per-
formed at the time of necropsy of inoculated and control pigs.
The PRRSV-infected PAMs were detected as early as day
4 p.i. The alkaline phosphatase precipitate was observed in the
cytoplasm within these labeled PAMs (Fig. 2A). The positive
ISH signal in PAMs was most frequently seen between 4 and 7
days p.i., when 4 to 10 positive cells per 105 cell spots were
observed. The signal then decreased until 14 days p.i. (to 1 cell
per 105 cell spots) and became undetectable afterward.
In tissues, the most abundant and consistent ISH signal was
observed in lung, especially at 4 and 7 days p.i. (Fig. 2B and D).
The positive cells typically displayed dark purple-staining de-
posits in the cytoplasm. The location and morphology of the
most frequent PRRSV-positive cells in the lung seem to indi-
cate that they were in alveolar macrophages. This observation
was also confirmed with consecutive serial sections stained
with hematoxylin-eosin (data not shown). In several cases, the
signal also coincided with a cell morphology and location that
would suggest that the cell could be classified as a type II
pneumocyte (Fig. 2B). In all cases the specificity of the signal
reaction was confirmed by the rigorous observance of three
specificity controls: (i) predigestion of a consecutive tissue
section with a solution of RNase A prior to the performance of
ISH which precluded or significantly decreased the develop-
ment of the ISH signal, (ii) ISH performed on consecutive
sections of infected tissues with a pseudorabies virus heterol-
ogous probe which likewise showed no positive signal, and (iii)
ISH performed with a PRRSV probe on tissues of uninfected
pigs which were consistently negative (data not shown). In
addition, proof of specificity was provided by the performance
of IHC on sections immediately consecutive to those on which
ISH was performed. The thickness of the section used (5 mm)
ensured that most positive cells would be present in both con-
secutive sections. The performance of IHC and ISH on serial
sections of lungs indicated a very close cell-to-cell correlation
between the signal of both techniques when they were per-
formed on samples taken during the acute p.i. period with any
PRRSV strain (4 and 7 days p.i.) (Fig. 2C and D). However,
when this simultaneous detection was performed at late p.i.
periods (at 28 days p.i. with PRRSV NEB-1-inoculated ani-
mals [11] and at 42 days p.i. with PRRSV 1534- and 94-2367-
inoculated animals), the signal by IHC was significantly de-
creased in a number of cells. The IHC-positive cells were also
positive by ISH, while many additional positive cells were only
evident in the ISH section (Fig. 2E and F).
In an attempt to confirm the identities of macrophages iden-
tified by histological morphology, we performed IHC on sec-
tions of tissues using two MAbs specific for swine macro-
phages. However, these MAbs were unsuccessful in staining
macrophage-rich areas of spleen, lung, and other swine tissues
(data not shown). In addition to lung tissue, we demonstrated
by ISH that between 4 and 42 days p.i. many PRRSV-infected
cells are localized in macrophage-rich areas of other tissues
including tonsil, thymus, bronchial lymph node, spleen, Peyer’s
patches of the ileum, and kidney. In the lung tissue, the his-
topathological changes were characterized by multifocal pro-
liferative interstitial pneumonia, septal infiltration with mono-
nuclear cells, and accumulation of macrophages with time
(data not shown). Bronchial lymph nodes from many of the
PRRSV-challenged pigs contained positive cells within lym-
phoid follicles, while a few positive cells were scattered in the
paracortical regions near germinal centers (Fig. 3A). PRRSV-
positive cells in the thymus were observed both in the thymic
medulla and the thymic cortex (Fig. 3B). PRRSV-positive cells
observed in tonsillar sections taken during the acute phase (4,
7, and 14 days p.i.) were found in both the tonsillar follicle and
the crypt epithelium (data not shown). Unlike other lymphoid
tissues, the spleen had only a few positive cells in germinal
centers of lymphoid nodules (data not shown).
FIG. 1. (A) PRRSV-infected MARC-145 cells hybridized with a DIG-labeled cDNA probe (433 bp) generated by RT-PCR from PRRSV ORF 7. (B) ISH of
mock-infected MARC-145 cells with the same probe used for panel A. Methyl green counterstain was used for both panels. Magnifications, 3625.
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PRRSV-positive cells observed in the kidney were found
predominantly in the renal medulla. These cells may be inter-
stitial macrophages (Fig. 3C). Additionally, PRRSV-positive
cells were observed within Peyer’s patches of the ileum (Fig.
3D). Positive cells appeared to decrease in number after 14
days p.i. At 42 days p.i. the only tissues in which viral RNA was
most consistently detected were the lung and tonsil (Fig. 3E &
F).
Viral infectivity in tissues. The results of isolation of infec-
tious PRRSV from replicates of the tissue samples analyzed by
ISH are presented in Table 1. In the case of both PRRSV-
inoculated groups (PRRSV 94-2367 and 1534), the isolation of
infectious PRRSV from tissue homogenates followed a pattern
consistent with that previously observed during acute replica-
tion of NEB-1 (11) and other PRRSV field isolates (24). Pos-
itive viral isolation from lung samples collected at 28 days after
infection with PRRSV NEB-1 has been reported previously
(11). Attempts to isolate virus from samples from the uninocu-
lated control group were negative (data not shown).
DISCUSSION
Here we report the detection of PRRSV RNA in tissue
sections and PAMs from pigs infected intranasally with this
virus and collected at different times, which ranged from 4 to
42 days p.i. ISH allowed us to detect PRRSV-specific RNA,
FIG. 2. (A) ISH performed on PAMs obtained by bronchial lavage upon necropsy of a PRRSV-infected pig at 7 days p.i. A positive ISH signal in the cytoplasm
of one PAM is shown in the center. Methyl green counterstain was used. Magnification, 3625. (B) PRRSV-infected cells in the lung of a pig at 7 days p.i. with PRRSV.
Large numbers of positive cells free in alveolar spaces and within the alveolar septae can be seen. Arrows indicate cells that by morphology and location could be
classified as type II pneumocytes. ISH was performed, and methyl green counterstain was used. Magnification, 3625. (C and D) Serial sections of the PRRSV-infected
lung tissue taken from an infected pig at 4 days p.i. (C) PRRSV-infected cells in alveolar septae. Immunoperoxidase with hematoxylin counterstain was used.
Magnification, 3250. (D) Serial section (5-mm thickness) of the cells in panel C processed by ISH for PRRSV RNA showing that the same cells positive for PRRSV
antigen (C) also contained PRRSV RNA. Methyl green counterstain was used. Magnification, 3250. (E and F) Serial sections of PRRSV-infected lung tissue taken
from PRRSV-infected pig at 28 days p.i. (E) A few PRRSV-infected cells in alveolar septae. Immunoperoxidase with hematoxylin counterstain was used. Magnification,
3200. (F) Serial section of the cells in panel E but processed by ISH for PRRSV RNA, showing that more abundant PRRSV-infected cells are present, in addition
to those positive for PRRSV antigen in panel E. Methyl green counterstain was used. Magnification, 3200.
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and its specificity was clearly established by appropriate con-
trols. The tissue with the highest signal intensity for PRRSV
infection at all times p.i. was lung. The localization of positive
signals in lung tissue was most abundant in the cytoplasm of
alveolar macrophages. This is consistent with what has been
previously reported by other laboratories on the basis of the
use of IHC (14, 15, 18, 20) and also our own IHC studies
reported here.
The extent of ISH signals in macrophages of lung sections at
early periods p.i. suggests that PAMs are a prime target of
PRRSV infection. However, in our studies PAMs obtained by
lavage did not exhibit, even at early periods of infection, a
significant frequency of positive cells. This low ratio of ISH-
positive PAMs does not necessarily reflect an in vivo situation;
it is possible that the procedure that we used to cytospin and fix
the PAMs for ISH selected against the attachment and reten-
tion of infected cells fixed on the slides. The possible involve-
ment of other respiratory cells (i.e., type II pneumocytes) in
the replication of PRRSV in the lung has been previously
suggested by IHC (14, 20). In addition, extensive hypertrophy
and hyperplasia of type II pneumocytes are known to occur
during acute PRRSV infection of the lung (6, 12, 16, 30). Our
ISH results give support to a role of type II pneumocytes in the
replication of PRRSV, because the lung sections in our exper-
iments showed cells which exhibited positive ISH signals and
which morphologically and topographically are consistent with
a type II pneumocyte identity (Fig. 2B). However, an unequiv-
ocal confirmation of pneumocytes as a site of replication of
FIG. 3. (A) Positive ISH signals in germinal center of bronchial lymph node of a pig at 4 days p.i. with PRRSV. Methyl green counterstain was used. Magnification,
3250. (B) Positive ISH signals in thymus of a pig at 4 days p.i. with PRRSV. Positive cells are located both in the thymic medulla and the thymic cortex. ISH was
performed, and methyl green counterstain was used. Magnification, 3250. (C) PRRSV-infected cells in the kidney of a pig at 7 days p.i. with PRRSV. Positive cells
are located in the interstitium of the renal medulla. ISH was performed, and methyl green counterstain was used. Magnification, 3625. (D) PRRSV-infected cells in
the ileum of a pig at 7 days p.i. with PRRSV. Positive cells are located in Peyer’s patches. ISH was performed, and methyl green counterstain was used. Magnification,
3625. (E) PRRSV-infected cells in the lung of a pig at 42 days p.i. with PRRSV. Positive cells are located in the alveolar septae. ISH was performed, and methyl green
counterstain was used. Magnification, 3625. (F) PRRSV-infected cells in the tonsil of a pig at 42 days p.i. with PRRSV. Positive cells are located in tonsillar follicle.
ISH was performed, and methyl green counterstain was used. Magnification, 3250.
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PRRSV will require further study of these positive cells by
other methods such as ultrastructural analysis by electron mi-
croscopy of the same tissue section used for ISH (that work is
in progress in our laboratory).
During the early phase of infection, PRRSV-positive cells
detected by ISH were noticeably more abundant in the lung
than in lymphoid tissues and kidney. The early appearance in
the lung of PRRSV RNA parallels reports of others of the
early isolation of infectious PRRSV from lung tissue (9, 29)
and correlates well with our own viral isolation assays (Table
1). This close temporal relationship between infectious virus
and viral RNA could suggest a possible direct viremia caused
by the replication of PRRSV in pulmonary macrophages which
would result in the release of PRRSV into the vascular com-
partment.
The controls included in our ISH protocol confirm the spec-
ificity of our PRRSV RNA in situ detection methodology.
More importantly, other compelling evidence that confirms the
specificity of our ISH protocol was provided by our simulta-
neous use of ISH and IHC with serial sections of the same
tissue. The IHC technique that we used was standardized and
described by previous investigators (14) and is based on the
detection of the PRRSV nucleocapsid antigen. It is remarkable
that during the acute phase of PRRSV infection many infected
cells were detected by IHC in the alveolar septae of the lung
and that these were in absolute correlation with the location of
these same cells containing PRRSV RNA determined by ISH
in the consecutive section. In this respect, we can say that the
sensitivities of ISH and IHC are equivalent and acceptable for
the detection of infected cells in the tissues of acutely infected
animals. This is perhaps due to the abundance of both PRRSV
antigens and genomic and subgenomic PRRSV RNAs in cells
actively replicating virus in the lung during early periods p.i.
However, when we compared both techniques at longer peri-
ods p.i., at which it is possible that a lower level of replication
takes place, it became obvious that ISH is more sensitive and
specific than IHC. We base this statement on the comparison
of consecutive serial sections at 28 days p.i. (Fig. 2E and F)
with one strain of PRRSV. The results obtained with sections
at 42 days p.i. with another strain of PRRSV (94-2367) were
consistent with this interpretation (data not shown). The dif-
ference in sensitivity between both techniques could presum-
ably be due to intrinsic differences of the techniques in ques-
tion. It is well known that antigen immunodetection requires
significantly higher numbers of target molecules than nucleic
acid hybridization to reach a specific signal which would be
consistent with a positive reaction (31). This was particularly
difficult to achieve by IHC because as the number of positive
cells decreased, the differentiation between signal and noise
became more difficult because of the higher level of back-
ground staining that is characteristic of IHC reactions. Alter-
natively, it may be argued that the superior sensitivity of ISH
over IHC at longer times p.i. is based on the fact that antigen
production in many of these infected cells has ceased or fallen
below the levels of detection, while PRRSV RNAs persisted in
the cells. Examples of the in vivo persistence of viral RNA
upon acute infection linked to minimal or no expression of
structural viral antigens are well known (1, 5, 19, 26). Further
studies on the transcriptional activity of PRRSV during per-
sistence by using single-stranded probes for ISH will certainly
clarify this issue. Our results indicated that the number of cells
supporting PRRSV infection during the late or persistent
phase is limited, these being most noticeable in lung and ton-
sils. In fact, at these periods p.i. the ISH assay was able to
detect PRRSV RNA while viral isolation attempts were neg-
ative (Table 1). This could also provide support to the concept
of the persistence of PRRSV at late periods p.i. in a noninfec-
tious form. However, it should be mentioned that routine as-
sessment of infectivity in tissue homogenates like the method
that we used in the experiments described here are less sensi-
tive than methods involving cocultivation of the target cells
(i.e., alveolar macrophages obtained by lavage) with indicator
cells, as described by Mengeling et al. (24). It is possible, then,
that if we had optimized the viral isolation procedures we
would have detected infectious PRRSV at longer times p.i.
PRRSV-positive signals in the kidney were observed within
cells morphologically resembling and whose location was con-
sistent with interstitial macrophages in the renal medulla at 4
and 7 days p.i. During the acute and persistent phases of
PRRSV infection we could not detect positive cells in heart
tissue by ISH (although some viral infectivity was detectable)
(Table 1). These results, although contrasting with the results
reported by Halbur et al. (15), are not surprising on the basis
TABLE 1. Detection of PRRSV 94-2367 and 1534 by ISH or infectivity assay
PRRSV strain Tissue
Finding by the indicated assay on the following day p.i.b:
4 7 14 42
VI ISH VI ISH VI ISH VI ISH
94-2367 Serum 1 NA 1 NA 1 NA 2 NA
Thymus 1 1 1 2 1 ND 2 2
Heart 2 2 2 2 2 ND 2 2
Lung 1 1 1 1 1 1 2 1
Spleen 2 1 2 6 2 6 2 2
Bronchia lymph node 1 1 1 1 1 1 2 2
Tonsil 1 1 1 1 1 1 2 1
1534 Serum 1 NA 1 NA 1 NA 2 NA
Thymus 1 1 1 1 1 1 2 2
Heart 1 2 1 2 2 ND 2 2
Lung 1 1 1 1 1 1 2 1
Spleen 1 1 1 1 1 1 2 2
Bronchia lymph node 1 ND 1 ND 1 1 2 2
Tonsil 1 ND 1 ND 2 1 2 1
a Viral isolation (VI) assays were conducted on tissues collected from two groups of pigs inoculated with either PRRSV 94-2367 or PRRSV 1534. Each observation
was made on samples collected from three animals also analyzed by ISH.
b 1, at least one of three animals was positive or negative by viral isolation or ISH signal; 6, weak ISH signal; ND, not done; NA, not applicable.
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of the known diversity of tissue tropism that exists among
different PRRSV strains (16).
Ultimate confirmation of the macrophage character of the
PRRSV-positive cells by IHC will require the use of different
MAbs whose specificity is not impaired by formalin fixation or
the use of a different fixation protocol (i.e., cryostat section
plus acetone fixation for IHC and PLP fixation for ISH in
consecutive sections).
Our study has demonstrated that ISH and IHC both detect
PRRSV-infected cells at different times p.i. However, ISH is
more sensitive and specific than IHC, especially when studying
PRRSV-infected cells at long periods p.i. The acute and per-
sistent phases of infection appear to be based mainly in mac-
rophages. This is consistent with what has been described for
the lactate dehydrogenase-elevating virus, the most studied
member of the genus Arterivirus (4). In view of the results
reported here, it is possible that the persistence of PRRSV in
vivo involves a continuous level of PRRSV replication in in-
fected cells. With the further use of ISH for transcription-
specific studies, we can anticipate that a more subtle molecular
analysis of persistent PRRSV infections can be achieved, al-
lowing a better understanding of the pathogenesis of PRRSV.
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